IMPlicating Mesenchymal Imp1 in Colitis-Associated Cancer.
Ekaterina K Koltsova1, Sergei I Grivennikov2
1Blood Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Molecular Cancer Research : MCR
|October 11, 2015
Summary
Hamilton and colleagues found that the RNA binding protein Imp1 in fibroblasts suppresses intestinal inflammation and colitis-associated cancer development. This highlights a key role for Imp1 in regulating inflammatory responses and carcinogenesis.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Chronic inflammation is a key driver of various diseases, including cancer.
- Fibroblasts play a critical role in regulating inflammation and carcinogenesis.
- The RNA binding protein Imp1 is implicated in cellular processes relevant to disease.
Purpose of the Study:
- To investigate the role of the RNA binding protein Imp1 in fibroblast-mediated regulation of intestinal inflammation.
- To determine the impact of Imp1 on the development of colitis-associated cancer.
Main Methods:
- The study focused on the fibroblast-specific function of Imp1.
- Investigated the suppression of intestinal inflammatory responses.
- Examined the development of colitis-associated cancer.
Main Results:
- Hamilton and colleagues identified a fibroblast-specific role for Imp1.
- Imp1 was found to suppress intestinal inflammatory responses.
- Imp1 activity was linked to the suppression of colitis-associated cancer development.
Conclusions:
- Fibroblast-specific Imp1 is a crucial regulator of intestinal inflammation.
- Imp1 plays a protective role in suppressing colitis-associated cancer.
- Targeting Imp1 in fibroblasts may offer therapeutic strategies for inflammatory diseases and cancer.
Related Concept Videos
Mesenchymal Stem Cells
6.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.0K
Cancer Stem Cells and Tumor Maintenance
6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance
2.3K
2.3K
Renewal of Intestinal Stem Cells
3.6K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.6K
Adult Stem Cells
34.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
34.4K


